Treatment of Bilateral Corneal Ulcers in an African Lioness Using Human Amniotic Membrane Allografts
American Association of Zoo Veterinarians Conference 2009
Sam Rivera1, DVM, MS, DABVP (Avian); Maria M. Crane1, DVM; Gail Powell-Johnson2, DVM; Rita McManamon3, DVM; Richard R. Dubielzig4, DVM
1Zoo Atlanta, Atlanta, GA, USA; 2Atlanta Veterinary Eye Clinic, Avondale Estates, GA, USA; 3Infectious Diseases Laboratory and Department of Pathology, University of Georgia, Athens, GA, USA; 4Pathobiology, University of Wisconsin, Madison, WI, USA

Abstract

An 18-year-old spayed female African lioness (Panthera leo) developed bilateral ulcerative keratoconjunctivitis, which was suspected to be secondary to depressed lacrimal function. The lioness was under treatment with steroids (prednisolone 1 mg/kg PO SID) for immune mediated anemia. The animal was treated with pilocarpine (0.02 mg/kg PO BID) to enhance tear production and oral systemic antibiotics (cephalexin 20 mg/kg PO BID). Two weeks later, bilateral allografts (OASIS Acelagraft Dehydrated Human Amniotic Membrane; www.oasismedical.com) were applied to the left and right corneal ulcers and were sutured in place. Subconjunctival injections of flurbiprofen and gentamicin were performed. Complete corneal healing, with corneal scars, were documented 5 weeks postsurgically. The animal died from unrelated causes, and a necropsy was performed.

Ulcerative corneal lesions occur in many species, including humans, domestic and exotic animals. Predisposing causes include trauma, suboptimal tear film production and/or composition due to aging or other reasons, immune system compromise, or immunosuppressive therapy. Prompt and effective repair of corneal defects is desirable in order to maintain or restore vision.1,2 Human amniotic grafts have been used as a biologic membrane to repair corneal defects in humans.3 The membrane provides mechanical protection, decreases the inflammatory response, acts as a basement membrane layer, contains growth and trophic factors, and expands the limbal stem cell population. In this case, histologic examination confirmed the presence of an effective healing response, through the use of this commercially available human product.

Acknowledgments

The authors thank Colleen Grace, MD for significant contributions to this paper and presentation, and Robert Hill for documentation of the surgical procedure.

Literature Cited

1.  Barros, P.S.M., A.M.V. Safatle, C.A. Godoy, M.S.B. Souza, L.F.M. Barros, and D.E. Brookes. 2005. Amniotic membrane transplantation for the reconstruction of the ocular surface in three cases. Vet. Ophthalm. 8:189–192.

2.  Barros, P.S.M., J.A. Garcia, J.L. Laus, A.L. Ferriera, and T.L. Salles Gomes. 1998. The use of xenologuous amniotic membrane to repair canine corneal perforation created by penetrating keratectomy. Vet. Ophthalm. 1:119–123.

3.  Hanada, K., J. Shimazaki, S. Shimura, et al. 2001. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am. J. Ophthalm. 131:324–331.

 

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Sam Rivera, DVM, MS, DABVP (Avian)
Zoo Atlanta
Atlanta, GA, USA


MAIN : AAZV Conference : Corneal Ulcers & Human Amniotic Membrane Allografts
Powered By VIN
SAID=27